Dr. Ghada M. Ahmed-Elsayed

Robyn Domsic, MD, specializes in rheumatology and is certified by the American Board of Internal Medicine. She practices at University of Pittsburgh Physicians, Department of Medicine, Division of Rheumatology and is affiliated with UPMC Children's Hospital of Pittsburgh, UPMC Magee-Womens Hospital, UPMC Presbyterian, and UPMC Mercy. She completed her medical degree at University of Iowa College of Medicine. Dr. Domsic is rated as a Distinguished provider by MediFind in the treatment of Raynaud Phenomenon. Her top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Raynaud Phenomenon, and Scleroma.

Veronica Newsome is a Rheumatologist in Du Bois, Pennsylvania. Dr. Newsome is rated as a Distinguished provider by MediFind in the treatment of Raynaud Phenomenon. Her top areas of expertise are Rheumatoid Arthritis (RA), Raynaud Phenomenon, Polymyositis, and Osteoporosis.

Robert Lafyatis, MD, is a rheumatologist and is certified in rheumatology by the American Board of Internal Medicine. He is  the Thomas Medsger Professor of Medicine at the University of Pittsburgh School of Medicine. He received his medical degree from University of Cincinnati and completed his residency at Wake Forest School of Medicine, followed by his fellowship at National Institutes of Health. Dr. Lafyatis’s clinical interests include systemic sclerosis (scleroderma) and its complications in the skin and lungs. His research interests include understanding the underlying cause of scleroderma and finding new treatments. Dr. Lafyatis directs the University of Pittsburgh/University of Pittsburgh Medical Center Scleroderma Center and the National Institutes of Health, Center for Scleroderma Research Translation.  He has over 200 peer-reviewed publications and co-authors the Textbook of Rheumatology chapter on Scleroderma Pathogenesis. Dr. Lafyatis is rated as a Distinguished provider by MediFind in the treatment of Raynaud Phenomenon. His top areas of expertise are Systemic Sclerosis (SSc), Scleroderma, Pulmonary Fibrosis, Scleroma, and Pancreaticoduodenectomy.